Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Boehringer Ingelheim

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Boehringer Ingelheim's 2013 sales performance.

Boehringer Ingelheim GmbH

Biogen loses another pipeline drug to toxicity concerns

Biogen loses another pipeline drug to toxicity concerns

In the interim, two drug treatments – Boehringer Ingelheim’s  Ofev(nintedanib) and Roche/Genentech’s  Esbriet(pirfenidone) – have been approved by the FDA for the disease and grown into blockbuster products ... Boehringer has its eyes on a

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

FDA fast-tracks AstraZeneca’s Farxiga in heart failure It also renews hope for the pharma company that it can chase down SGLT2 market leader Jardiance (empagliflozin) from Eli Lilly and Boehringer Ingelheim.

Boehringer bags FDA OK for Ofev in rare lung disease ILD

Boehringer bags FDA OK for Ofev in rare lung disease ILD First drug approved for condition. Boehringer Ingelheim’s Ofev has become the first drug approved by the FDA for a lung disease that afflicts patients with systemic sclerosis, a rare autoimmune ... Ofev is already a blockbuster seller for Boehringer,

Amgen reveals more data on KRAS drug

Amgen reveals more data on KRAS drug race, which include Mirati,   Boehringer Ingelheim, Johnson &Johnson/Wellspring, Merck/Moderna and AstraZeneca/Ionis.

Boehringer bolsters KRAS push with $720m Lupin deal

Boehringer bolsters KRAS push with $720m Lupin deal Signs of progress in the field are emerging. Boehringer Ingelheim has licensed a MEK inhibitor from India’s Lupin that it intends to pair with its stable of KRAS inhibitors, a ... For Lupin, Boehringer is the second big biopharma partner for its

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Alzheimers
Detecting Alzheimer’s ahead of a cure
A focus on promising new research...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Can you survive without the blue dot?
Or has the digital world has replaced our brain...

Infographics